扩大反应化学工具箱 - - 选核弹头用于共价布基胆酶抑制剂
Anže Meden1, Xavier Brazzolotto2, José Dias2
1University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Aškerčeva 7, SI-1000, Ljubljana, Slovenia.
Chemico-biological interactions
|November 23, 2025
概括
研究人员选了电友化合物对共价胆化酶抑制的检测,确定了开发针对人类胆化酶 (hBChE) 和其他氨酸酸酶的新型抑制剂的最佳结构.
科学领域:
- 药用化学 医学化学
- 酶抑制可以抑制酶.
- 药物发现 药物发现 药物发现
背景情况:
- 胆酶抑制剂对于治疗各种神经系统疾病至关重要.
- 协同抑制剂提供长时间的酶抑制,但需要谨慎设计,以确保选择性和安全性.
- 已知胆酶抑制剂中常见的是像卡巴莫伊尔,索和硫基等电友性部分.
研究的目的:
- 为了选各种电友分群对胆化酶的共价抑制.
- 为了确定结构-活性关系,控制对人类丁胆化酶 (hBChE) 的共价结合.
- 探索新的支架和化学型,以开发强效和选择性的共价hBChE抑制剂.
主要方法:
- 选各种电友核弹头,包括碳酸盐,酸盐和硫酸盐.
- 在选择性hBChE抑制剂支架上安装电友或作为碎片大小的化合物.
- 评估依赖时间的酶抑制作为对共价 adduct 形成的标记.
- 分析结构-反应性关系,重点关注离开组属性和固体效应.
主要成果:
- 七-醇替代模式是最佳的时间依赖性抑制.
- 碳酸盐化学型产生了最依赖时间的抑制剂.
- 抑制剂的反应性与离开组的酸度相关 (pKa <10),促进了催化血清碳amylation.
- 炭基甲基卡巴霍尔类似物对一般的反应性趋势构成了例外.
结论:
- 阐明了对共价hBChE抑制剂的关键结构-活性关系.
- 这些发现为设计针对氨酸酸酶的新型共价抑制剂提供了基础.
- 优化的支架和化学型可以导致更有效的治疗剂.
相关概念视频
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
873
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
873
01:22Cholinesterases: Distribution and Function
884
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
884
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
02:34Regioselectivity and Stereochemistry of Acid-Catalyzed Hydration
9.4K
The rate of acid-catalyzed hydration of alkenes depends on the alkene's structure, as the presence of alkyl substituents at the double bond can significantly influence the rate.
9.4K
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.6K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.6K
01:30Enzyme Inhibition
91.0K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.0K